Zhejiang Huakang Pharmaceutical Résultats passés
Passé contrôle des critères 1/6
Zhejiang Huakang Pharmaceutical has been growing earnings at an average annual rate of 6.8%, while the Food industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 20.1% per year. Zhejiang Huakang Pharmaceutical's return on equity is 9%, and it has net margins of 10%.
Informations clés
6.8%
Taux de croissance des bénéfices
-0.9%
Taux de croissance du BPA
| Food Croissance de l'industrie | 7.2% |
| Taux de croissance des recettes | 20.1% |
| Rendement des fonds propres | 9.0% |
| Marge nette | 10.0% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Ventilation des recettes et des dépenses
Comment Zhejiang Huakang Pharmaceutical gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 2,846 | 284 | 190 | 123 |
| 30 Jun 24 | 2,773 | 325 | 161 | 129 |
| 31 Mar 24 | 2,767 | 361 | 139 | 136 |
| 31 Dec 23 | 2,783 | 371 | 128 | 124 |
| 30 Sep 23 | 2,654 | 339 | 113 | 124 |
| 30 Jun 23 | 2,619 | 363 | 122 | 105 |
| 31 Mar 23 | 2,445 | 359 | 120 | 97 |
| 31 Dec 22 | 2,200 | 319 | 114 | 100 |
| 30 Sep 22 | 1,994 | 308 | 108 | 96 |
| 30 Jun 22 | 1,813 | 263 | 94 | 105 |
| 31 Mar 22 | 1,671 | 236 | 88 | 90 |
| 31 Dec 21 | 1,594 | 237 | 87 | 84 |
| 30 Sep 21 | 1,519 | 257 | 89 | 85 |
| 30 Jun 21 | 1,344 | 237 | 80 | 73 |
| 31 Mar 21 | 1,311 | 253 | 74 | 73 |
| 31 Dec 20 | 1,320 | 307 | 67 | 65 |
| 30 Sep 20 | 1,350 | 297 | 203 | 94 |
| 31 Dec 19 | 1,511 | 270 | 161 | 54 |
| 31 Dec 18 | 1,400 | 199 | 126 | 44 |
| 31 Dec 17 | 925 | 56 | 112 | 28 |
| 31 Dec 16 | 763 | 29 | 89 | 22 |
Des revenus de qualité: 605077 has a high level of non-cash earnings.
Augmentation de la marge bénéficiaire: 605077's current net profit margins (10%) are lower than last year (12.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 605077's earnings have grown by 6.8% per year over the past 5 years.
Accélération de la croissance: 605077's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 605077 had negative earnings growth (-16.4%) over the past year, making it difficult to compare to the Food industry average (-6%).
Rendement des fonds propres
ROE élevé: 605077's Return on Equity (9%) is considered low.